Blood Studies for Cardiovascular System III: Serum Lipid Profile
Myocarditis III: Medical Management
Overview of Lipid Metabolism
Acute Pancreatitis II: Clinical Manifestations and Management
Myocarditis II: Clinical Features and Diagnostic Tests
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 19, 2025

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
Julia McNabb-Baltar1,2, David X Jin1,2, Amit S Grover2,3
1Division of Gastroenterology, Hepatology, and Endoscopy, Center for Pancreatic Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mild hyperlipasemia occurred in 12.1% of hospitalized coronavirus disease (COVID-19) patients. However, no patients developed acute pancreatitis, suggesting COVID-19 does not significantly impact pancreatic function.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: